345 related articles for article (PubMed ID: 9591259)
1. The power of genomics to transform the biotechnology industry.
Haseltine WA
Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259
[No Abstract] [Full Text] [Related]
2. In silico drug discovery: tools for bridging the NCE gap.
Larvol BL; Wilkerson LJ
Nat Biotechnol; 1998 May; 16 Suppl():33-4. PubMed ID: 9591262
[No Abstract] [Full Text] [Related]
3. The evolving role of collaboration in biotechnology.
Gower JM
Nat Biotechnol; 1998 May; 16 Suppl():31-2. PubMed ID: 9591261
[No Abstract] [Full Text] [Related]
4. Biotechnology's metamorphosis into a drug discovery industry.
Drews J
Nat Biotechnol; 1998 May; 16 Suppl():22-4. PubMed ID: 9591258
[No Abstract] [Full Text] [Related]
5. Rediscovering plant-based drugs.
Littleton J; Falcone D; Davies HM
Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
[No Abstract] [Full Text] [Related]
6. Biotechnology partnerships--medicine for an ailing industry?
DeLamarter J
Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
[No Abstract] [Full Text] [Related]
7. Prescription for an ailing pharmaceutical industry.
Demain AL
Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826
[No Abstract] [Full Text] [Related]
8. Private company profiles.
Nat Biotechnol; 2002 Jul; 20 Suppl():BE15-21. PubMed ID: 12089572
[No Abstract] [Full Text] [Related]
9. Optimizing the impact of genomics on drug discovery and development.
Crooke ST
Nat Biotechnol; 1998 May; 16 Suppl():29-30. PubMed ID: 9591260
[No Abstract] [Full Text] [Related]
10. Venturing into drug discovery.
Steinmetz M
Nat Biotechnol; 1998 May; 16 Suppl():17. PubMed ID: 9591255
[No Abstract] [Full Text] [Related]
11. Deal watch: Trends in platform technology deal-making.
Walker J; Jacob J
Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
[No Abstract] [Full Text] [Related]
12. Antibacterial drug discovery: is small pharma the solution?
Boggs AF; Miller GH
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038
[TBL] [Abstract][Full Text] [Related]
13. The end of the beginning?
Nat Rev Drug Discov; 2006 Sep; 5(9):705. PubMed ID: 17001798
[No Abstract] [Full Text] [Related]
14. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
Razvi ES
IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
[No Abstract] [Full Text] [Related]
15. The impact of systems approaches on biological problems in drug discovery.
Hood L; Perlmutter RM
Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
[No Abstract] [Full Text] [Related]
16. Private company profiles.
Nat Biotechnol; 2003 Jul; 21 Suppl():BE23-8. PubMed ID: 12874973
[No Abstract] [Full Text] [Related]
17. Advancing in the face of conventional wisdom.
Lanzara R
Drug Discov Today; 2004 Feb; 9(3):110-1. PubMed ID: 14960386
[No Abstract] [Full Text] [Related]
18. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
Federsel HJ
Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
[TBL] [Abstract][Full Text] [Related]
19. The lost science of formulation.
Brown MB
Drug Discov Today; 2005 Nov; 10(21):1405-7. PubMed ID: 16243254
[No Abstract] [Full Text] [Related]
20. Transforming the work of early-stage drug discovery through bioprocess informatics.
Holzman TF; Hebert EJ
Drug Discov Today; 2005 Jan; 10(1):61-7. PubMed ID: 15676300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
